A detailed history of Grove Bank & Trust transactions in Baxter International Inc stock. As of the latest transaction made, Grove Bank & Trust holds 97 shares of BAX stock, worth $2,820. This represents 0.0% of its overall portfolio holdings.

Number of Shares
97
Previous 2,126 95.44%
Holding current value
$2,820
Previous $71,000 95.77%
% of portfolio
0.0%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$32.85 - $40.26 $66,652 - $81,687
-2,029 Reduced 95.44%
97 $3,000
Q3 2023

Oct 30, 2023

SELL
$37.32 - $49.29 $20,526 - $27,109
-550 Reduced 20.55%
2,126 $80,000
Q2 2023

Jul 27, 2023

SELL
$39.98 - $47.68 $12,793 - $15,257
-320 Reduced 10.68%
2,676 $121,000
Q4 2022

Feb 03, 2023

BUY
$49.7 - $57.71 $148,901 - $172,899
2,996 New
2,996 $153,000
Q2 2022

Jul 29, 2022

SELL
$63.83 - $80.0 $192,766 - $241,600
-3,020 Closed
0 $0
Q1 2022

Apr 22, 2022

BUY
$76.85 - $89.45 $2,689 - $3,130
35 Added 1.17%
3,020 $234,000
Q2 2021

Jul 28, 2021

SELL
$80.5 - $88.01 $402 - $440
-5 Reduced 0.17%
2,985 $240,000
Q4 2020

Feb 03, 2021

BUY
$75.39 - $82.36 $1,432 - $1,564
19 Added 0.64%
2,990 $240,000
Q3 2020

Oct 30, 2020

BUY
$78.33 - $90.73 $548 - $635
7 Added 0.24%
2,971 $239,000
Q2 2020

Jul 31, 2020

SELL
$78.66 - $94.14 $1,809 - $2,165
-23 Reduced 0.77%
2,964 $255,000
Q1 2020

May 05, 2020

BUY
$71.57 - $93.3 $1,646 - $2,145
23 Added 0.78%
2,987 $243,000
Q3 2019

Oct 30, 2019

BUY
$81.4 - $89.78 $21,164 - $23,342
260 Added 9.62%
2,964 $259,000
Q2 2019

Jul 24, 2019

SELL
$73.44 - $82.41 $440 - $494
-6 Reduced 0.22%
2,704 $221,000
Q1 2019

Apr 26, 2019

BUY
$64.48 - $81.31 $174,740 - $220,350
2,710 New
2,710 $220,000
Q1 2018

May 07, 2018

SELL
$62.56 - $72.26 $142,949 - $165,114
-2,285 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$59.5 - $64.61 $135,957 - $147,633
2,285
2,285 $143,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Grove Bank & Trust Portfolio

Follow Grove Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.